Glucagon-Like Peptide Medication: Types, Uses, and Safety

Glucagon-like peptide medications are prescription drugs that copy the action of GLP-1, a hormone your gut releases after you eat. They are FDA-approved to treat type 2 diabetes, and several are also approved for chronic weight management in people who meet specific criteria. They are not over-the-counter products, and they do not replace diet, exercise, or ongoing medical care.

What a Glucagon-Like Peptide Medication Actually Is

The natural hormone, glucagon-like peptide-1, is released from cells in the small intestine within minutes of a meal. It then acts on the pancreas, the stomach, and the brain to help the body manage incoming food.

If you are wondering what does glucagon-like peptide 1 do, the short answer is that it slows stomach emptying, increases insulin release when blood sugar is high, and signals fullness to the brain. Your body breaks the natural hormone down within a couple of minutes, which is why drug versions are engineered to last for days.

Prescription versions are longer-lasting and much more potent than the hormone your body makes. That is what turns a brief gut signal into a once-weekly injection or a daily pill.

Types of Glucagon-Like Peptide Drugs

Most glucagon-like peptide-1 drugs belong to the same family, but they differ in dosing, delivery, and approved uses. The table below is a general overview; labels and approvals change over time, so always check current prescribing information.

Active ingredient	Common brand names	Typical dosing	Approved uses
Semaglutide	Ozempic, Wegovy, Rybelsus	Weekly injection or daily oral tablet	Type 2 diabetes; chronic weight management (Wegovy)
Liraglutide	Victoza, Saxenda	Once-daily injection	Type 2 diabetes; weight management (Saxenda)
Dulaglutide	Trulicity	Weekly injection	Type 2 diabetes
Exenatide	Byetta, Bydureon	Twice-daily or weekly injection	Type 2 diabetes
Tirzepatide	Mounjaro, Zepbound	Weekly injection	Type 2 diabetes; chronic weight management (Zepbound)

All of these medications are injected except oral semaglutide, which must be taken on an empty stomach with a small amount of water. Tirzepatide is often grouped with GLP-1 drugs, but it is a dual agonist that targets both GIP and GLP-1 receptors, and that difference matters when comparing results and side effects.

How These Medications Work in the Body

Every glucagon-like peptide-1 receptor agonist binds to the same receptor the natural hormone uses. The result is a slower, steadier rise in blood sugar after meals and a stronger, longer-lasting feeling of fullness.

Appetite changes often appear within the first week or two, while A1C and weight changes usually take two to three months to become clear. Because the drugs also slow stomach emptying, many people feel satisfied with smaller portions.

These medications are not fat burners. They change appetite signals and digestion, so weight loss still depends on eating fewer calories over time, which is easier for some people than others. That is a major reason research on glucagon-like peptide-1 weight loss has attracted so much attention.

Approved Uses: Diabetes, Weight, and Beyond

• Type 2 diabetes: A1C reductions of roughly 1 to 2 percentage points are common.
• Weight management: Wegovy, Saxenda, and Zepbound are approved for chronic weight management in adults who meet specific BMI criteria.
• Heart and kidney risk: Some GLP-1 medications have shown cardiovascular and kidney benefits in large clinical trials.

Doctors typically prescribe weight-management versions for a body mass index of 30 or higher, or 27 or higher with at least one weight-related condition such as high blood pressure or type 2 diabetes.

Side Effects and Safety Considerations

Nausea, vomiting, diarrhea, constipation, and stomach pain are the most commonly reported side effects, especially during dose increases. Many people find that these ease after a few weeks.

Less common but serious risks include pancreatitis, gallbladder disease, and severe gastroparesis. The medications are not recommended during pregnancy, and they are not for people with a personal or family history of medullary thyroid cancer or MEN2 syndrome.

Loss of lean muscle is another concern during rapid weight loss. A healthcare professional can help you protect muscle mass with enough protein and resistance training.

Glucagon-like peptide medications are not FDA-approved for cosmetic weight loss, and they should be used only under medical supervision.

Supplements and Related Peptides

Store shelves now carry GLP-1 support capsules and powders. Most dietary supplements marketed for GLP-1 support have little clinical evidence behind their claims, and they are not regulated the way prescription drugs are.

Other hormones in the same family do different jobs. Glucagon-like peptide-2 helps maintain the lining of the intestine and is the basis of a prescription drug for short bowel syndrome, so it has nothing to do with appetite or weight.

If cost or supply is a problem, ask about insurance coverage, manufacturer savings programs, or compounded versions from licensed pharmacies. Compounded drugs are not FDA-approved and can vary in quality, so they carry added uncertainty.

Questions to Ask Your Doctor

1. Is this medication approved for my condition, or would it be off-label?
2. What dose schedule and follow-up plan do you recommend?
3. Which side effects mean I should call you right away?
4. How will we track blood sugar, weight, and lean muscle over time?

Bring a complete list of everything you take, including supplements and other prescriptions. Some interactions and health conditions change the risk-benefit picture.

COMMON QUESTIONS

Frequently Asked Questions

Is Ozempic a glucagon-like peptide medication?

Yes. Ozempic is the brand name for semaglutide, a GLP-1 receptor agonist approved to treat type 2 diabetes. Wegovy contains the same active ingredient but is approved for chronic weight management. Both require a prescription and medical supervision.

How much weight can you lose on a GLP-1 medication?

In large clinical trials, participants taking semaglutide lost about 15 percent of body weight on average, and those taking tirzepatide lost about 20 percent, alongside diet and exercise. Results vary widely from person to person, and weight often returns if the medication is stopped. These drugs are designed for long-term use rather than short-term fixes.

Are there over-the-counter glucagon-like peptide supplements?

There are over-the-counter supplements marketed for GLP-1 support, but they are not FDA-approved drugs and the evidence behind them is limited. The approved GLP-1 and dual-agonist medications are prescription-only. Talk with a pharmacist or doctor before relying on a supplement for blood sugar or weight goals.